Analysis of rational drug use in the cancer hospital based on performance evaluation
10.3760/cma.j.cn115355-20240304-00097
- VernacularTitle:基于绩效考核的肿瘤医院药物合理使用情况分析
- Author:
Yongqiang LYU
1
;
Hongxia YAN
Author Information
1. 山西省肿瘤医院 中国医学科学院肿瘤医院山西医院 山西医科大学附属肿瘤医院运营管理部，太原 030013
- Keywords:
Hospital management;
Neoplasms;
Pharmacy administration;
Pharmacists;
Performance evaluation
- From:
Cancer Research and Clinic
2024;36(6):459-463
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the impact of performance evaluation on the rational use of clinical drugs in the cancer hospital.Methods:The rational drug use performance evaluation group of Shanxi Province Cancer Hospital combined the average value of each index from 2017 to 2019 to determine the target value of each evaluation index, and assigned the corresponding performance score and established the rational drug use performance evaluation system. The proportion of national essential drug use, the intensity of antimicrobial drug use, the proportion of the amount of adjuvant drug use and the drug selection in the process of drug use, drug dosage, administration route, administration frequency, administration course, solvent or solvent dosage, overuse of drug with indication, drug use beyond the instruction, and contraindication to the dispensing of drug, and other indicators from January 2019 to December 2022 in Shanxi Province Cancer Hospital were retrospectively analyzed.Results:The national essential drug use rate in hospitalized patients increased from 20.17% in 2019 to 57.30% in 2022; the intensity of antimicrobial drug use decreased from 12.07 number of defined daily doses (DDDs) in 2019 to 12.00 DDDs in 2022, and showed a decreasing trend year by year; the percentage of the amount of adjuvant drug use decreased from 2.60% in 2019 to 0.01% in 2022. From 2019 to 2022, the unreasonable rate of all assessment indicators decreased year by year, of which the rate of inappropriate drug selection decreased from 39.20% to 5.30%, the rate of inappropriate drug dosage decreased from 8.80% to 1.10%, the rate of inappropriate administration route decreased from 4.70% to 0.10%, the rate of inappropriate administration frequency decreased from 11.70% to 1.10%, the rate of inappropriate administration course decreased from 10.10% to 0.90%, the rate of inappropriate solvent or solvent dosage decreased from 21.10% to 7.30%, the rate of overuse of drug with indication decreased from 15.30% to 0.70%, the rate of drug use beyond the instruction decreased from 2.60% to 0.10%, and the rate of contraindication to the dispensing of drug decreased from 0.20% to 0.Conclusions:The refined performance evaluation system for rational use of drugs can effectively control the drug costs in the cancer hospital and promote rational use of drugs in clinics.
